• Je něco špatně v tomto záznamu ?

HLA-G 5'URR regulatory polymorphisms are associated with the risk of developing gliomas

V. Durmanova, K. Kluckova, B. Filova, G. Minarik, J. Kozak, B. Rychly, M. Svajdler, V. Matejcik, J. Steno, M. Bucova

. 2023 ; 133 (4) : 365-374. [pub] 20210928

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23003735

BACKGROUND: Human leukocyte antigen G (HLA-G) belongs to non-classical MHC class I molecules that is involved in the suppression of immune response. As HLA-G plays important role in the maintenance of fetal tolerance, its overexpression has been associated with tumor progression. For the regulation of HLA-G levels, genetic variants within the 5' upstream regulatory region (5'URR) are of crucial importance. Our study aimed to analyze the association between 16 HLA-G 5'URR variants, sHLA-G level and clinical variables in glioma patients. METHODS: We investigated 59 patients with gliomas (mean age 54.70 ± 15.10 years) and 131 healthy controls (mean age 41.45 ± 9.75 years). Patient's blood was obtained on the day of surgical treatment. The HLA-G 5'URR polymorphisms were typed by direct sequencing and the plasma level of sHLA-G assessed by ELISA. RESULTS: Haploblock within HLA-G 5'URR consisting of -762T, -716G, -689G, -666T, -633A, followed by -486C and -201A alleles were significantly more frequent in patients with gliomas than in the controls (p < 0.05). No correlation of HLA-G 5'URR variants with sHLA-G plasma level was found. Analysis of HLA-G 5'URR variants with main clinical variables in patients with grade IV gliomas revealed that haploblock carriers of -762CT, -716TG, -689AG, -666GT, -633GA, -486AC, -477GC, -201GA followed by -369AC carriers tend to have lower age at onset as compared to other genotype carriers (p = 0.04). CONCLUSION: Our results suggest genetic association of HLA-G 5'URR variants with risk of developing gliomas and possible contribution of HLA-G to disease pathology.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23003735
003      
CZ-PrNML
005      
20230425140840.0
007      
ta
008      
230418s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/00207454.2021.1922401 $2 doi
035    __
$a (PubMed)33902385
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Durmanova, Vladimira $u Institute of Immunology, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovakia $1 https://orcid.org/0000000174220194 $7 xx0118475
245    10
$a HLA-G 5'URR regulatory polymorphisms are associated with the risk of developing gliomas / $c V. Durmanova, K. Kluckova, B. Filova, G. Minarik, J. Kozak, B. Rychly, M. Svajdler, V. Matejcik, J. Steno, M. Bucova
520    9_
$a BACKGROUND: Human leukocyte antigen G (HLA-G) belongs to non-classical MHC class I molecules that is involved in the suppression of immune response. As HLA-G plays important role in the maintenance of fetal tolerance, its overexpression has been associated with tumor progression. For the regulation of HLA-G levels, genetic variants within the 5' upstream regulatory region (5'URR) are of crucial importance. Our study aimed to analyze the association between 16 HLA-G 5'URR variants, sHLA-G level and clinical variables in glioma patients. METHODS: We investigated 59 patients with gliomas (mean age 54.70 ± 15.10 years) and 131 healthy controls (mean age 41.45 ± 9.75 years). Patient's blood was obtained on the day of surgical treatment. The HLA-G 5'URR polymorphisms were typed by direct sequencing and the plasma level of sHLA-G assessed by ELISA. RESULTS: Haploblock within HLA-G 5'URR consisting of -762T, -716G, -689G, -666T, -633A, followed by -486C and -201A alleles were significantly more frequent in patients with gliomas than in the controls (p < 0.05). No correlation of HLA-G 5'URR variants with sHLA-G plasma level was found. Analysis of HLA-G 5'URR variants with main clinical variables in patients with grade IV gliomas revealed that haploblock carriers of -762CT, -716TG, -689AG, -666GT, -633GA, -486AC, -477GC, -201GA followed by -369AC carriers tend to have lower age at onset as compared to other genotype carriers (p = 0.04). CONCLUSION: Our results suggest genetic association of HLA-G 5'URR variants with risk of developing gliomas and possible contribution of HLA-G to disease pathology.
650    _2
$a lidé $7 D006801
650    _2
$a dospělí $7 D000328
650    _2
$a lidé středního věku $7 D008875
650    _2
$a senioři $7 D000368
650    12
$a HLA-G antigeny $x genetika $7 D059951
650    _2
$a haplotypy $7 D006239
650    12
$a polymorfismus genetický $x genetika $7 D011110
650    _2
$a genotyp $7 D005838
650    _2
$a alely $7 D000483
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kluckova, Kristina $u Institute of Immunology, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovakia $1 https://orcid.org/0000000318273800
700    1_
$a Filova, Barbora $u Institute of Medical Physics, Biophysics, Informatics and Telemedicine, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovakia
700    1_
$a Minarik, Gabriel $u Department of Molecular Biology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia
700    1_
$a Kozak, Jan $u Department of Neurosurgery, Faculty of Medicine, Comenius University and University Hospital Bratislava, Bratislava, Slovakia
700    1_
$a Rychly, Boris $u Department of Pathology, Cytopathos, Bratislava, Slovakia
700    1_
$a Svajdler, Marian $u Department of Pathology, Cytopathos, Bratislava, Slovakia $u Sikl's Department of Pathology, Charles University, The Faculty of Medicine and Faculty Hospital in Pilsen, Prague, Czech Republic $1 https://orcid.org/0000000180524741 $7 xx0092880
700    1_
$a Matejcik, Viktor $u Department of Neurosurgery, Faculty of Medicine, Comenius University and University Hospital Bratislava, Bratislava, Slovakia $1 https://orcid.org/0000000190514803
700    1_
$a Steno, Juraj $u Department of Neurosurgery, Faculty of Medicine, Comenius University and University Hospital Bratislava, Bratislava, Slovakia $1 https://orcid.org/0000000340077769
700    1_
$a Bucova, Maria $u Institute of Immunology, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovakia $1 https://orcid.org/0000000347423505 $7 mzk2007390479
773    0_
$w MED00011505 $t The International journal of neuroscience $x 1563-5279 $g Roč. 133, č. 4 (2023), s. 365-374
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33902385 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425140837 $b ABA008
999    __
$a ok $b bmc $g 1924423 $s 1189944
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 133 $c 4 $d 365-374 $e 20210928 $i 1563-5279 $m International Journal of Neuroscience $n Int J Neurosci $x MED00011505
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Možnosti archivace